Labeler
Camber Pharmaceuticals, Inc. NDC Codes
Camber Pharmaceuticals, Inc. lists 643 finished drug products in the FDA NDC Directory under NDC labeler code 31722.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Buprenorphine and Naloxone, Milnacipran Hydrochloride, Olmesartan medoxomil, amlodipine and hydrochlorothiazide, Eltrombopag, Topiramate, Pomalidomide, Fluphenazine Hydrochloride, mirtazapine, Afatinib, Losartan Potassium And Hydrochlorothiazide, Cisatracurium Besylate, Oxycodone Hydrochloride, spironolactone, Olmesartan medoxomil and hydrochlorothiazide, Sacubitril and valsartan
- Active ingredients
- Hydrochlorothiazide, Olmesartan medoxomil, Buprenorphine hydrochloride, Amlodipine besylate, Eltrombopag olamine, Naloxone hydrochloride, Topiramate, Milnacipran hydrochloride, Pomalidomide, Fluphenazine hydrochloride, Mirtazapine, Afatinib dimaleate
- NDC labeler codes
- 31722
- Strengths (from the 100 most recently listed products)
- Hydrochlorothiazide 12.5 mg/1; Olmesartan medoxomil 40 mg/1; Hydrochlorothiazide 25 mg/1; Buprenorphine hydrochloride 2 mg/1; Buprenorphine hydrochloride 8 mg/1; Amlodipine besylate 5 mg/1; Olmesartan medoxomil 20 mg/1; Sugammadex sodium 100 mg/mL; Losartan potassium 100 mg/1; Cisatracurium besylate 2 mg/mL; Amlodipine besylate 10 mg/1; Acetaminophen 325 mg/1; Levodopa 100 mg/1; Carbidopa 25 mg/1; Eltrombopag olamine 25 mg/1; Eltrombopag olamine 12.5 mg/1; Clomiphene citrate 50 mg/1; Glycerol phenylbutyrate 1.1 g/mL; Afatinib dimaleate 20 mg/1; Afatinib dimaleate 30 mg/1
- Dosage forms
- Tablet, Film coated, Tablet, Capsule, Capsule, Extended release, Injection, Solution, Film, Soluble, Injection, Solution, Powder, For suspension, Kit, Suspension, Tablet, Extended release, Liquid, Powder, For solution, Injection, Powder, Lyophilized, For solution, Suppository
- Routes
- Oral, Sublingual, Intravenous, Buccal, Rectal, Subcutaneous, Intramuscular
- Drug classes (FDA established)
- Angiotensin 2 Receptor Blocker, Thiazide Diuretic, Partial Opioid Agonist, Opioid Antagonist, Kinase Inhibitor, Phenothiazine, Opioid Agonist, Calcium Channel Blocker, Dihydropyridine Calcium Channel Blocker, Thrombopoietin Receptor Agonist, Serotonin and Norepinephrine Reuptake Inhibitor, Thalidomide Analog, Nondepolarizing Neuromuscular Blocker, Serotonin Reuptake Inhibitor, Aldosterone Antagonist, Neprilysin Inhibitor, Aromatic Amino Acid, Histamine-1 Receptor Antagonist, Aminoketone, Serotonin-1b and Serotonin-1d Receptor Agonist, Serotonin-4 Receptor Agonist, Chloride Channel Activator, Estrogen Agonist/Antagonist, Nitrogen Binding Agent, Amino Acid, Sigma-1 Agonist, Uncompetitive N-methyl-D-aspartate Receptor Antagonist, Central Nervous System Depressant, Aminosalicylate, Azole Antifungal, Tetracycline-class Drug, Nonsteroidal Anti-inflammatory Drug, Nitrofuran Antibacterial, Hematopoietic Stem Cell Mobilizer, Calculi Dissolution Agent, Osmotic Laxative, Retinoid, Factor Xa Inhibitor
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 184 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Temozolomide | Temozolomide 250 mg/1 | CapsuleOral | 31722-416 | 31722-0416-1431722-0416-31 | — |
| Lurasidone Hydrochloride | Lurasidone hydrochloride 60 mg/1 | Tablet, Film coatedOral | 31722-082 | 31722-0082-0531722-0082-3031722-0082-90 | — |
| Lurasidone Hydrochloride | Lurasidone hydrochloride 20 mg/1 | Tablet, Film coatedOral | 31722-080 | 31722-0080-0531722-0080-3031722-0080-90 | — |
| Lurasidone Hydrochloride | Lurasidone hydrochloride 40 mg/1 | Tablet, Film coatedOral | 31722-081 | 31722-0081-0531722-0081-3031722-0081-90 | — |
| Lurasidone Hydrochloride | Lurasidone hydrochloride 80 mg/1 | Tablet, Film coatedOral | 31722-083 | 31722-0083-0531722-0083-3031722-0083-90 | — |
| Lurasidone Hydrochloride | Lurasidone hydrochloride 120 mg/1 | Tablet, Film coatedOral | 31722-084 | 31722-0084-0531722-0084-3031722-0084-90 | — |
| Dabigatran Etexilate | Dabigatran etexilate mesylate 110 mg/1 | CapsuleOral | 31722-666 | 31722-0666-3231722-0666-60 | — |
| Nimodipine | Nimodipine 60 mg/20mL | SolutionOral | 31722-039 | 31722-0039-47 | — |
| Dicyclomine hydrochloride | Dicyclomine hydrochloride 10 mg/1 | CapsuleOral | 31722-052 | 31722-0052-0131722-0052-0531722-0052-10 | — |
| Pemetrexedpemetrexed disodium | Pemetrexed disodium hemipentahydrate 100 mg/4mL | Injection, Powder, Lyophilized, For solutionIntravenous | 31722-336 | 31722-0336-31 | — |
| Pemetrexedpemetrexed disodium | Pemetrexed disodium hemipentahydrate 500 mg/20mL | Injection, Powder, Lyophilized, For solutionIntravenous | 31722-337 | 31722-0337-31 | — |
| Avanafil | Avanafil 50 mg/1 | TabletOral | 31722-440 | 31722-0440-0131722-0440-30 | — |
| Avanafil | Avanafil 100 mg/1 | TabletOral | 31722-441 | 31722-0441-0131722-0441-30 | — |
| Avanafil | Avanafil 200 mg/1 | TabletOral | 31722-442 | 31722-0442-0131722-0442-30 | — |
| Erlotinib | Erlotinib hydrochloride 100 mg/1 | Tablet, Film coatedOral | 31722-264 | 31722-0264-30 | — |
| Erlotinib | Erlotinib hydrochloride 25 mg/1 | Tablet, Film coatedOral | 31722-263 | 31722-0263-30 | — |
| Erlotinib | Erlotinib hydrochloride 150 mg/1 | Tablet, Film coatedOral | 31722-265 | 31722-0265-30 | — |
| Melphalan Hydrochloride | — | Kit | 31722-362 | 31722-0362-31 | — |
| Phenylephrine Hydrochloride | Phenylephrine hydrochloride 10 mg/mL | InjectionIntravenous | 31722-344 | 31722-0344-31 | — |
| Phenylephrine Hydrochloride | Phenylephrine hydrochloride 10 mg/mL | InjectionIntravenous | 31722-343 | 31722-0343-3231722-0343-33 | — |
| Phenylephrine Hydrochloride | Phenylephrine hydrochloride 10 mg/mL | InjectionIntravenous | 31722-345 | 31722-0345-1031722-0345-31 | — |
| Decitabine | Decitabine 50 mg/10mL | Injection, Powder, Lyophilized, For solutionIntravenous | 31722-304 | 31722-0304-31 | — |
| Dicyclomine hydrochloride | Dicyclomine hydrochloride 20 mg/1 | TabletOral | 31722-079 | 31722-0079-0131722-0079-10 | — |
| Bortezomib | Bortezomib 3.5 mg/1 | Injection, Powder, Lyophilized, For solutionIntravenous, Subcutaneous | 31722-303 | 31722-0303-31 | — |
| pitavastatin calcium | Pitavastatin calcium 2.09 mg/1 | Tablet, Film coatedOral | 31722-876 | 31722-0876-90 | — |
| pitavastatin calcium | Pitavastatin calcium 1.045 mg/1 | Tablet, Film coatedOral | 31722-875 | 31722-0875-90 | — |
| pitavastatin calcium | Pitavastatin calcium 4.18 mg/1 | Tablet, Film coatedOral | 31722-877 | 31722-0877-90 | — |
| Colchicine | Colchicine .6 mg/1 | CapsuleOral | 31722-099 | 31722-0099-0131722-0099-1031722-0099-30 | — |
| Voriconazole | Voriconazole 10 mg/mL | Injection, Powder, Lyophilized, For solutionIntravenous | 31722-224 | 31722-0224-31 | — |
| Bupivacaine Hydrochloride | Bupivacaine hydrochloride 5 mg/mL | Injection, SolutionEpidural, Intracaudal, Perineural | 31722-276 | 31722-0276-3131722-0276-3231722-0276-33+1 more | — |
| Bupivacaine Hydrochloride | Bupivacaine hydrochloride 2.5 mg/mL | Injection, SolutionEpidural, Infiltration, Intracaudal, Perineural | 31722-275 | 31722-0275-3131722-0275-3231722-0275-33+2 more | — |
| Bupivacaine Hydrochloride | Bupivacaine hydrochloride 7.5 mg/mL | Injection, SolutionEpidural, Retrobulbar | 31722-277 | 31722-0277-3131722-0277-3231722-0277-33+1 more | — |
| capecitabine | Capecitabine 150 mg/1 | Tablet, Film coatedOral | 31722-774 | 31722-0774-60 | — |
| capecitabine | Capecitabine 500 mg/1 | Tablet, Film coatedOral | 31722-775 | 31722-0775-1231722-0775-60 | — |
| Gabapentin | Gabapentin 300 mg/1 | Tablet, Film coatedOral | 31722-091 | 31722-0091-90 | — |
| Gabapentin | Gabapentin 600 mg/1 | Tablet, Film coatedOral | 31722-092 | 31722-0092-90 | — |
| Icosapent Ethyl | Icosapent ethyl .5 g/1 | CapsuleOral | 31722-298 | 31722-0298-24 | — |
| Icosapent Ethyl | Icosapent ethyl 1 g/1 | CapsuleOral | 31722-299 | 31722-0299-12 | — |
| Mesalamine | Mesalamine 1.2 g/1 | Tablet, Delayed releaseOral | 31722-043 | 31722-0043-0531722-0043-12 | — |
| Gabapentin | Gabapentin 250 mg/5mL | SolutionOral | 31722-069 | 31722-0069-47 | — |
| Fesoterodine Fumarate | Fesoterodine fumarate 4 mg/1 | Tablet, Film coated, Extended releaseOral | 31722-033 | 31722-0033-3031722-0033-90 | — |
| Fesoterodine Fumarate | Fesoterodine fumarate 8 mg/1 | Tablet, Film coated, Extended releaseOral | 31722-034 | 31722-0034-3031722-0034-90 | — |
| Eszopiclone | Eszopiclone 1 mg/1 | Tablet, Film coatedOral | 31722-855 | 31722-0855-0131722-0855-30 | — |
| Eszopiclone | Eszopiclone 2 mg/1 | Tablet, Film coatedOral | 31722-856 | 31722-0856-0131722-0856-30 | — |
| Eszopiclone | Eszopiclone 3 mg/1 | Tablet, Film coatedOral | 31722-857 | 31722-0857-0131722-0857-30 | — |
| Rufinamide | Rufinamide 40 mg/mL | SuspensionOral | 31722-688 | 31722-0688-46 | — |
| Diatrizoate Meglumine and Diatrizoate Sodium | Diatrizoate meglumine 660 mg/mL; Diatrizoate sodium 100 mg/mL | SolutionOral, Rectal | 31722-019 | 31722-0019-3131722-0019-32 | — |
| Aripiprazolearipiprazole oral | Aripiprazole 1 mg/mL | SolutionOral | 31722-684 | 31722-0684-15 | — |
| Pantoprazole Sodium | Pantoprazole sodium 40 mg/1 | Granule, Delayed releaseOral | 31722-032 | 31722-0032-32 | — |
| Vareniclinevarenicline tartrate | Varenicline tartrate 1 mg/1 | Tablet, Film coatedOral | 31722-679 | 31722-0679-3131722-0679-56 | — |
Camber Pharmaceuticals, Inc.: common questions
- What is Camber Pharmaceuticals, Inc.'s NDC labeler code?
- 31722. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Camber Pharmaceuticals, Inc.?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.